Close Menu

NEW YORK (GenomeWeb) – Purigen Biosystems said today that it has raised $18.2 million in a Series A financing round, and plans to use the funds to further develop and commercialize its technology for automated preparation of genomic and genetic testing samples.

The round was led by 5AM Ventures and Roche Venture Fund, the company said, with participation from existing investors the Stanford-Startx Fund and Western Investments Capital.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Hastings Center's Erik Parens argues in a Scientific American opinion piece that the current pandemic underscores the need to reconsider the hope placed in genomic medicine. 

The Los Angeles Times writes that Operation Warp Speed has an ambitious timeline for developing a COVID-19 vaccine.

The Sydney Morning Herald reports that Australia is launching its trial of preconception carrier testing Tuesday.

In PNAS this week: autosomal genes commonly affected by loss-of-function variants, variants implicated in testis development disorders, and more.